No. 25A587
Novartis Pharmaceuticals Corporation v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Key Terms:
SocialSecurity FirstAmendment FifthAmendment Takings Punishment JusticiabilityDoctri
SocialSecurity FirstAmendment FifthAmendment Takings Punishment JusticiabilityDoctri
Latest Conference:
N/A
Question Presented (AI Summary)
Whether the Supreme Court should grant a pharmaceutical company an extension of time to file a petition for certiorari in a case involving significant regulatory or consumer protection issues
Question Presented (OCR Extract)
No question identified. :
Docket Entries
2025-12-11
Application (25A587) granted by Justice Alito extending the time to file until January 23, 2026.
2025-12-08
Application of Novartis Pharmaceuticals Corp. for a further extension of time submitted.
2025-12-08
Application (25A587) to extend further the time from January 9, 2026 to January 23, 2026, submitted to Justice Alito.
2025-11-20
Application (25A587) granted by Justice Alito extending the time to file until January 9, 2026.
2025-11-14
Application (25A587) to extend the time to file a petition for a writ of certiorari from December 10, 2025 to February 8, 2026, submitted to Justice Alito.
Attorneys
Novartis Pharmaceuticals Corp.
Gregory George Garre — Latham & Watkins LLP, Petitioner
Secretary United States Department of Health and Human Services, et al.
D. John Sauer — Solicitor General, Respondent